PhaseBio Pharmaceuticals, Inc. (PHAS)

Net Change in Cash

-$56.65M

TTM · Period ending: · USD

PHAS logo

PHAS Net Change in Cash

Latest reported-$56.65M
PHAS Net Change in Cash (-$438.00K → -$56.65M)
High-resolution chart · PNG

PHAS net change in cash history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Net Change in Cash — Annual fiscal periods (USD)
Period endingNet Change in Cash (USD)
13,678,000
-45,903,000
12,974,000
47,625,000
9,691,000
-438,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.